CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $2.19B, above the global median of $1.15B
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.56%
Annual Rate
CNY 0.26Paid semi-annual
Payout Ratio
29.7%Sustainable
Payback Period
65.6 yr
Last Ex-Dividend
Jun 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
14.78BCNY2.19B · vs all stocks (USD)
Trailing P/E
48.53xvs Medical Devices peers
Revenue (TTM)
1.73BCNY256.98M · vs all stocks (USD)
Profit Margin
16.61%vs Medical Devices peers
Beta
0.7540xvs all stocks
52-Week Change
16.07%vs all stocks
Market Capitalization
14.78BCNY2.19B · vs all stocks (USD)
Enterprise Value
12.32BCNY1.83B · vs all stocks (USD)
Trailing P/E
48.53xvs Medical Devices peers
Forward P/E
29.47xvs Medical Devices peers
Price to Sales (TTM)
8.02xvs Medical Devices peers
Price to Book (MRQ)
3.66xvs Medical Devices peers
Enterprise to Revenue
7.11xvs Medical Devices peers
Enterprise to EBITDA
28.61xvs Medical Devices peers
Gross Margin
41.31%vs Medical Devices peers
Profit Margin
16.61%vs Medical Devices peers
Operating Margin
20.03%vs Medical Devices peers
Return on Assets (TTM)
5.05%vs Medical Devices peers
Return on Equity (TTM)
7.88%vs Medical Devices peers
Revenue (TTM)
1.73BCNY256.98M · vs all stocks (USD)
Revenue per Share (TTM)
2.19CNYUpdated Aug 19, 2026Quarterly Revenue Growth
36.30%vs Medical Devices peers
Gross Profit (TTM)
663.06MCNY98.33M · vs all stocks (USD)
EBITDA (TTM)
320.21MCNY47.49M · vs all stocks (USD)
Net Income (TTM)
287.89MCNY42.69M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
9.30%vs Medical Devices peers
Operating Cash Flow (TTM)
421.44MCNY62.50M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-285.97MCNY-42.41M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2571CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
1.56%vs all stocks
Payout Ratio
29.69%vs Medical Devices peers
Revenue
1.63BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
973.79MCNYFY2025 · Dec 31, 2025Gross Profit
651.70MCNYFY2025 · Dec 31, 2025Operating Income
338.72MCNY50.23M · vs all stocks (USD)
Pre-tax Income
324.70MCNYFY2025 · Dec 31, 2025Income Tax Expense
41.62MCNYFY2025 · Dec 31, 2025Net Income
283.08MCNYFY2025 · Dec 31, 2025EBIT
325.66MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
474.28MCNYFY2025 · Dec 31, 2025Research & Development
133.82MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
40.37MCNYFY2025 · Dec 31, 2025Other Operating Expenses
17.18MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
47.52MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
958.88KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3571CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3571CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
792.63MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
792.63MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
283.08MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
189.66MCNYFY2025 · Dec 31, 2025Free Cash Flow
-270.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.09BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
283.08MCNYFY2025 · Dec 31, 2025Other Non-cash Items
15.76MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-33.36MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-75.83MCNYFY2025 · Dec 31, 2025Capital Expenditures
-460.07MCNYFY2025 · Dec 31, 2025Sale of Investments
6.80MCNYFY2025 · Dec 31, 2025Other Investing Activity
367.75MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-85.52MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
71.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-41.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-84.85MCNYFY2025 · Dec 31, 2025Other Financing Charges
73.26MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
18.41MCNYFY2025 · Dec 31, 2025Shares Outstanding
796.42MSharesUpdated Aug 19, 2026Float Shares
221.92MSharesUpdated Aug 19, 2026% Held by Insiders
70.79%vs all stocks
% Held by Institutions
5.24%vs all stocks
Total Cash (MRQ)
1.66BCNY246.54M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.09CNYUpdated Aug 19, 2026Total Debt (MRQ)
111.38MCNY16.52M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0294xvs Medical Devices peers
Current Ratio (MRQ)
6.27xvs Medical Devices peers
Book Value per Share (MRQ)
4.77CNYUpdated Aug 19, 2026Total Assets
4.23BCNY627.88M · vs all stocks (USD)
Total Current Assets
2.46BCNYFY2025 · Dec 31, 2025Total Liabilities
500.43MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.78BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
70.84MCNYFY2025 · Dec 31, 2025Total Current Liabilities
429.59MCNYFY2025 · Dec 31, 2025Cash
1.41BCNYFY2025 · Dec 31, 2025Cash Equivalents
44.51MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.45BCNYFY2025 · Dec 31, 2025Other Short-term Investments
212.10MCNYFY2025 · Dec 31, 2025Accounts Receivable
376.77MCNYFY2025 · Dec 31, 2025Inventory
379.15MCNYFY2025 · Dec 31, 2025Accounts Payable
178.01MCNYFY2025 · Dec 31, 2025Short-term Debt
108.74MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.33MCNYFY2025 · Dec 31, 2025Long-term Debt
2.70MCNYFY2025 · Dec 31, 2025Common Stock (Book)
568.87MCNYFY2025 · Dec 31, 2025Retained Earnings
1.57BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.73BCNY553.67M · vs all stocks (USD)
Treasury Stock
29.43MCNYFY2025 · Dec 31, 202552-Week Low
13.89CNYUpdated Aug 19, 202652-Week High
30.93CNYUpdated Aug 19, 202652-Week Change
16.07%vs all stocks
Beta
0.7540xvs all stocks
50-Day MA
18.07CNYUpdated Aug 19, 2026200-Day MA
19.27CNYUpdated Aug 19, 2026Avg 10-Day Volume
12.14MSharesUpdated Aug 19, 2026Avg 30-Day Volume
16.34MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.3600CNYUpdated Aug 19, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $2.19B, above the global median of $1.15BNotable
Market cap (USD): 2,192,037,733.581Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Mesoblast Limited
Tier 1ProductionApproval-Gated PipelineRule
Wedge Industrial Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Fujian Cosunter Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sionna Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Iovance Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zai Lab Limited
Tier 1ProductionApproval-Gated PipelineRuleRisk
Neogen Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Granules India Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jinyu Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pfizer Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Hangzhou XZB Tech Co., Ltd.
4 interpretationsHigh Retained Earnings With Profitability And EquityPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown
Mueller Industries Inc.
3 interpretationsHigh Retained Earnings With Profitability And EquityUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown
Pourin Special Welding Technology Co., Ltd.
3 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown